The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
ProKidney Corp (NASDAQ: PROK) closed the day trading at $2.5 up 1.63% from the previous closing price of $2.46. In other words, the price has increased by $1.63 from its previous closing price. On the day, 0.95 million shares were traded. PROK stock price reached its highest trading level at $2.5699 during the session, while it also had its lowest trading level at $2.41.
Upgrades & Downgrades
In the most recent recommendation for this company, H.C. Wainwright on December 16, 2025, initiated with a Buy rating and assigned the stock a target price of $12. On June 30, 2025, BofA Securities Downgraded its rating to Underperform which previously was Neutral but kept the price unchanged to $1.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 13 ’25 when Pereira Brian JG sold 502,136 shares for $2.37 per share. The transaction valued at 1,190,062 led to the insider holds 0 shares of the business.
Pereira Brian JG sold 255,026 shares of PROK for $694,515 on Nov 12 ’25. The Director now owns 54,333 shares after completing the transaction at $2.72 per share. On Nov 12 ’25, another insider, Brian Pereira, who serves as the Director of the company, bought 675,234 shares for $2.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 752085888 and an Enterprise Value of 1412732672. For the stock, the TTM Price-to-Sale (P/S) ratio is 1016.33. Its current Enterprise Value per Revenue stands at 1898.834 whereas that against EBITDA is -8.584.
Stock Price History:
The Beta on a monthly basis for PROK is 1.82, which has changed by 0.36666667 over the last 52 weeks, in comparison to a change of 0.13927746 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -3.85%, while the 200-Day Moving Average is calculated to be 28.28%.
Shares Statistics:
Over the past 3-months, PROK traded about 1.67M shares per day on average, while over the past 10 days, PROK traded about 1481510 shares per day. A total of 135.98M shares are outstanding, with a floating share count of 105.52M. Insiders hold about 25.45% of the company’s shares, while institutions hold 28.52% stake in the company. Shares short for PROK as of 1764288000 were 14786117 with a Short Ratio of 8.83, compared to 1761868800 on 12294628. Therefore, it implies a Short% of Shares Outstanding of 14786117 and a Short% of Float of 14.37.
Earnings Estimates
Its stock is currently analyzed by 6.0 different market analysts. The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.16 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.41 and -$1.07 for the fiscal current year, implying an average EPS of -$0.59. EPS for the following year is -$0.64, with 6.0 analysts recommending between -$0.42 and -$1.2.
Revenue Estimates
5 analysts predict -$39.4k in revenue for. The current quarter. It ranges from a high estimate of $250k to a low estimate of -$447k. As of. The current estimate, ProKidney Corp’s year-ago sales were $76k
